title: Monitoring and treatment of minimal residual cancer of the prostate.
authors.forename: G
authors.initials: G
authors.lastname: Mathé
authors.forename: A V
authors.initials: AV
authors.lastname: Schally
authors.forename: A M
authors.initials: AM
authors.lastname: Comaru-Schally
authors.forename: R Y
authors.initials: RY
authors.lastname: Mauvernay
authors.forename: M L
authors.initials: ML
authors.lastname: Vovan
authors.forename: D
authors.initials: D
authors.lastname: Machover
authors.forename: J L
authors.initials: JL
authors.lastname: Misset
authors.forename: B
authors.initials: B
authors.lastname: Court
authors.forename: P
authors.initials: P
authors.lastname: Bouchard
authors.forename: J
authors.initials: J
authors.lastname: Duchier
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000628:therapy; D000469:Alkaline Phosphatase / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008055:Lipids / Q000032:analysis; D008297:Male; D019158:N-Acetylneuraminic Acid; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D012794:Sialic Acids / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D008055:Lipids; D012794:Sialic Acids; C054080:lipid-associated sialic acid; D000469:Alkaline Phosphatase; D019158:N-Acetylneuraminic Acid